Document Detail


Phyto-oestrogens and osteoporosis: what is a safe dose?
MedLine Citation:
PMID:  12725659     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hormone replacement therapy (HRT) for preventing loss of bone following the menopause is utilised by only 8-10 % of possible users, largely due to a fear of increased risk of breast cancer. Plant oestrogen-like compounds (phyto-oestrogens) have been proposed as an alternative to HRT to prevent osteoporosis. One class of phyto-oestrogens (the isoflavones) is found in soya foods and red clover. The food industry is developing a wide variety of new foods containing soya to substantially increase isoflavone intake, as well as extracting isoflavones from soya and clover to use as additives to non-soya foods. Pharmaceutical companies are also preparing isoflavone extracts to be used in pill form. In each case the targeted delivery is approximately 50 mg of isoflavones/d. Is this dose of isoflavones safe? In this review of the current literature, it is concluded that isoflavones consumed orally and in doses below 2 mg/kg body weight per d should be considered safe for most population groups. Whether these doses are sufficient to prevent osteoporosis is a separate matter.
Authors:
Stephen Barnes
Related Documents :
8137319 - Potential of food modification in cancer prevention.
15772439 - Selenium distribution in wheat grain, and the effect of postharvest processing on wheat...
16857839 - Method of defining equol-producer status and its frequency among vegetarians.
1852729 - Changes in the nutritive value of soy protein concentrate during autoclaving.
23586739 - Cyanobacterial diversity in the hot spring, pelagic, and benthic habitats of a tropical...
17913229 - Selenium.
23603219 - In-situ immuno-gold nanoparticle network elisa biosensors for pathogen detection.
19211529 - The influence of copper concentration and source on ileal microbiota.
7317809 - Water consumption and the effects of water restriction on performance of broilers in th...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  The British journal of nutrition     Volume:  89 Suppl 1     ISSN:  0007-1145     ISO Abbreviation:  Br. J. Nutr.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-05-02     Completed Date:  2003-07-10     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0372547     Medline TA:  Br J Nutr     Country:  England    
Other Details:
Languages:  eng     Pagination:  S101-8     Citation Subset:  IM    
Affiliation:
Department of Pharmacology & Toxicology, and Comprehensive Cancer Center, University of Alabama at Birmingham, 35294, USA. sbarnes@uab.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / prevention & control
Diet*
Female
Humans
Isoflavones / administration & dosage*,  adverse effects,  blood
Middle Aged
Neoplasms, Hormone-Dependent / prevention & control
Osteoporosis, Postmenopausal / prevention & control*
Soybeans / chemistry
Grant Support
ID/Acronym/Agency:
5R01 CA-61668/CA/NCI NIH HHS; P50 AT00477-01/AT/NCCAM NIH HHS
Chemical
Reg. No./Substance:
0/Isoflavones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Investigating the role of natural phyto-oestrogens on bone health in postmenopausal women.
Next Document:  Measuring cognition in menopause research: a review of test use.